Pharmaceutical Executive Digital Edition - June 2011
Emerging Pharma Leaders 2011
Educating Physicians
FDA's opiod REMS implies there is still value in industry-sponsored CME
To Genzyme, Quality Data Depends on Quality Governance
The payoff is superior performance in key areas such as clinical trials
Be Courageous
Carefully crafting your brand's positioning could ensure that you'll not just win the sprint, but also the marathon
2011 Dealmakers Outlook
With Yankee stadium as the backdrop, Pharm Exec convened its annual panel of eight business development experts to crack the bat on best practice in licensing and M&A for the year ahead.
Drugstore Vaccinations
NicVAX is trying to buck the trend of smoking-cessation products' high failure rate
Branding a Unique Story
Pharma company communicators must steer the conversation about vaccines to the ultimate goal-preventing disease
A Lack of Information
Why has the EU still not managed to update its rules on information about medicines?
Getting IT Together
NeHC's new Consumer Consortium is promoting a new stakeholder agenda to improve patient knowledge
The Futuristic Insight
Creating and managing expectations is the most basic rule of marketing
Optimizing your Value with Payers
Successful negotiations require a willingness to take risks and an ability to adapt
Managing Product Lifecycle
Patent expiries are inevitable, but brand teams should look to graduate the sales curve
To Screen or Not to Screen?
What do our genetics tell us about our predisposition to certain diseases?
Start Serious, Become Bolder
A vaccination against addiction could open up a whole new category
Safe and Effective, Really?
To decide on a course of treatment, patients need to be told the truth straight up
Reach A Diverse Audience
The three components of the NicVAX launch challenge
Learn From What Follows
With a first-in-class compound marketers can potentially leverage long-lasting market advantages
How to Be More Truthful
Suggestions for testing new ways of addressing difficult issues of risk
